MedPath

The efficacy of Cerebrolysin in the treatment of acute ischemic stroke

Phase 3
Conditions
Cerebral infarction.
Cerebral infarction
Registration Number
IRCT138803272042N1
Lead Sponsor
Research Deputy, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

patients aged 45 to 85 years, the occurrence of acute cerebral ischemic attack (embolic or thrombotic), hospitalization during 12 hours of first symptoms of stroke, systolic blood pressure less than 200 and diastolic less than 100 mmHg

Exclusion Criteria

recovery of neurologic symptoms after 4 hours of attack, hemorrhagic stroke or the occurrence of stroke in vertebrobasilar system with blood pressure =200/100 mmHg, seizures, Papilledema or rising intracranial pressure (RICP), neck stiffness or symptoms of brain stimulation, the condition of consciousness stupor and coma (GCS = 6), acute myocardial infarction, National Institutes of Health Stroke Scale (NIHSS) less than 7 and more than 24, hepatic or renal failure - heart failure, dementia initial appearance, acute infectious disease, doubt the Involvement in subsequent brain area (posterior circulation), pregnant women, symptoms of progressive neurologic defects, patients who are in other trials, patients received piracetam or calcium channel blockers (CCB), Patients who received r-TPA treatment during first 4 hours of symptoms

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical evaluation of motor ability (speech and motor ability of patients). Timepoint: daily. Method of measurement: MRS (Modified Rankin Scale), NIHSS (National Institutes of Health Stroke Scale).
Secondary Outcome Measures
NameTimeMethod
Improvement in the understanding of patients during the treatment. Timepoint: On days 3, 7, 15 and 30. Method of measurement: Asessment of CGIS (Clinical Global Impression Scale), PGS (Patient Global Satisfaction Score) and MMSE (Mini-Mental State Exam) by neurologist.
© Copyright 2025. All Rights Reserved by MedPath